Page 25 - Loss Attributable News Today

16.05.2022 - Sale Leaseback Transactions with IIPR include Massachusetts and Pennsylvania Facilities Net Proceeds from Both Transactions Expected to Reduce Existing Debt by up to 50% PHOENIX, May 16, 2022 (GLOBE NEWSWIRE) - TILT Holdings Inc. (“TILT” or the ...

/PRNewswire/ -- Inpixon® (Nasdaq: INPX), the Indoor Intelligence® company, today provided a business update and reported financial results for its 2022 first...

– Company advances innovative rare disease and immuno-oncology portfolio toward ‘4x24’ goal of four registrational programs in 2024 – – Poster presentation at ASCO 2022... | May 16, 2022

Management's Discussion and Analysis of Financial Condition and Results of Operations

VANCOUVER, BC / ACCESSWIRE / May 13, 2022 / GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company"), a global leader in the agricultural and commercial development of high-quality zero-calorie natural

12.05.2022 - Continued Strength in Buyer Demand Drives Year-over-Year Sales Increase of 106.0%TACOMA, Wash., May 12, 2022 (GLOBE NEWSWIRE) - Harbor Custom Development, Inc. (“Harbor,” “Harbor Custom Homes,” or the “Company”), (NASDAQ: HCDI; HCDIP; HCDIW, ...

/PRNewswire/ -- Nuvve Holding Corp. (Nuvve) (Nasdaq: NVVE), a global cleantech company electrifying the planet at the intersection of energy and transportation...

/PRNewswire/ -- Nuvve Holding Corp. (Nuvve) (Nasdaq: NVVE), a global cleantech company electrifying the planet at the intersection of energy and transportation...

Four Clinical Readouts Anticipated Throughout 2022 Mechanistic Data on FS118 Demonstrating Shedding Mechanism and LAG-3 Reduction Presented at the 2022 American Association for Cancer Research (AACR)

F-star Therapeutics, Inc. (NASDAQ: FSTX) (“F-star” or the “Company”), a clinical-stage biopharmaceutical company dedicated to developing next-generation immunotherapies to transform the lives of patients with cancer, today announced first quarter 2022 financial results and provided a corporate update ...